Graphene quantum dots as anti-inflammatory therapy for colitis

Area of Science:

• Nanomedicine
• Immunology
• Gastroenterology

Background:

• Graphene derivatives are explored for nanomedicine applications, but their role in immune disorders is unclear.
• Graphene quantum dots (GQDs) exhibit low toxicity and easy clearance, suggesting potential for treating intestinal bowel diseases (IBDs).

Purpose of the Study:

• To investigate the therapeutic efficacy of GQDs in a dextran sulfate sodium (DSS)-induced mouse model of acute and chronic colitis.
• To elucidate the immunomodulatory mechanisms of GQDs in the context of intestinal inflammation.

Main Methods:

• Intraperitoneal injection of GQDs in DSS-induced acute and chronic colitis models.
• Assessment of tissue degeneration, intestinal inflammation, T helper cell polarization (T_H1/T_H17), macrophage polarization (M1/M2), and regulatory T cell (T_reg) infiltration.

Main Results:

• GQDs effectively prevented tissue degeneration and ameliorated intestinal inflammation.
• GQDs inhibited T_H1 and T_H17 cell polarization.
• GQDs promoted a shift in macrophage polarization from M1 to M2 and enhanced T_reg infiltration in the intestine.

Conclusions:

• GQDs demonstrate significant therapeutic potential for treating autoimmune disorders, particularly IBDs.
• The anti-inflammatory effects of GQDs are mediated through the regulation of key immune cell populations.
• GQDs represent a promising alternative therapeutic agent for managing excessive intestinal inflammation.